ADVFN US – Market Content Editor
-
Intel Sees EU Antitrust Fine Cut by 140 Million Euros
The General Court of the European Union has ruled to lower Intel’s (NASDAQ:INTC) antitrust penalty from 376 million euros ($438 million) to 237.1 million euros, though it declined the company’s bid to have the sanction thrown out entirely. “An amount of 237,105,540 euros is a more appropriate reflection of the gravity and duration of the…
-
Amid surging prices a new tungsten mine is about to open in South Korea
Almonty Industries (NASDAQ:ALM) (TSX:AII) CEO Lewis Black updates investors on the Sangdong tungsten mine in South Korea at The International Investment Forum, a premier online platform delivering expert insights into global trends across industries, including mining, energy and biotechnology, connecting with top executives worldwide through interactive sessions, all without travel — promoting sustainability and efficiency. This…
-
U.S. Stocks Close Narrowly Mixed Ahead Of Fed Decision
Following the modest pullback seen during trading on Monday, stocks turned in a lackluster performance during Tuesday’s session. The major averages fluctuated over the course of the session before closing narrowly mixed. While the tech-heavy Nasdaq inched up 30.58 points or 0.1 percent to 23,576,49, the S&P 500 edged down 6.00 points or 0.1 percent…
-
Spotify rolls out music videos for U.S. and Canadian premium users as it intensifies rivalry with YouTube
Spotify (NYSE:SPOT) announced Tuesday that premium subscribers in the U.S. and Canada will soon gain access to music videos, marking a major step in the company’s effort to compete more directly with YouTube in the video–music space. The expansion builds on Spotify’s initial beta launch last year across nearly 100 markets. By adding video content—viewed…
-
Tronox shares surge after lining up potential $600M in rare earth project financing
Tronox Holdings (NYSE:TROX) rallied 28% after announcing it has received conditional backing for as much as $600 million in potential financing from the Export-Import Bank of the United States (EXIM) and Export Finance Australia (EFA). The funds would help advance the company’s expansion into the rare earth supply chain. The coordinated, non-binding letters of support…
-
U.S. Job Openings Come In Well Above Forecasts, Offering Support for the Dollar
Fresh data from the JOLTs Job Openings survey showed U.S. labor demand running hotter than expected, with vacancies climbing to 7.670 million, according to the Bureau of Labor Statistics. The reading came in noticeably above economists’ projections, marking a clear upside surprise for markets. JOLTs job openings measure positions that meet three key criteria: a…
-
SES AI Shares Drop After Wolfpack Research Publishes Critical Short Report
SES AI Corporation (NYSE:SES) saw its shares decline 5% on Tuesday after short-seller Wolfpack Research published a sharply critical report raising questions about the company’s strategy, partnerships, and recent acquisitions. In its report, “SES’s Dying Biz Pivoting into Another AI Pipedream,” Wolfpack alleges that SES AI has been promoting “phantom deals” and touting an AI…
-
Q/C Technologies Shares Jump as Company Brings Martin Shkreli Onboard as Strategic Advisor
Q/C Technologies, Inc. (NASDAQ:QCLS) saw its stock surge 20% on Tuesday morning after the quantum-class computing firm revealed that Martin Shkreli has joined the company as a Strategic Advisor — marking a high-profile return to the business arena for the polarizing former pharmaceutical executive. The company, which develops computing architectures that rely on light instead…
-
C3 AI Shares Gain After Company Wins U.S. Army Contract for Battlefield Logistics Technology
C3 AI (NYSE:AI) traded 2% higher on Tuesday after announcing it has been awarded a contract by the U.S. Army to build an artificial intelligence–powered logistics system intended to support combat operations. The selection, made by the Army’s Rapid Capabilities and Critical Technologies Office (RCCTO), tasks C3 AI with creating AI-enabled tools that can help…
-
Akari Therapeutics Shares Climb After Encouraging Early Data for Pancreatic Cancer Candidate
Akari Therapeutics PLC (NASDAQ:AKTX) saw its stock rise 7.9% in premarket trading on Tuesday after unveiling new preclinical findings showing that its investigational antibody-drug conjugate, AKTX-101, successfully eliminated cancer cells carrying K-Ras G12V mutations in pancreatic cancer models. According to the company, AKTX-101—designed to target the Trop2 protein frequently overexpressed in pancreatic tumors—demonstrated “single digit…